No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Ethicon Physiomesh Lawsuits Pile Up

Ethicon Physiomesh trials to start next year and thousands more are waiting in the wings

Thursday, July 5, 2018 - The most common forms of hernia repair surgery are those to fix groin, abdominal, and umbilical ruptures. A hernia can be described as "a condition in which part of an organ protruded through the wall of the cavity containing it, usually the abdominal or intestinal walls." According to, hernias are easily diagnosed as a visible bump or bulge in the intestine or stomach area. Hernias usually cause discomfort but not severe pain. Severe pain around the site of a bulge could be a sign of a serious condition such as a tumor. Hernias usually take time and develop gradually while others appear suddenly and can require emergency medical attention. A hernia bulge will normally disappear when the patient lies down and reappear when the patients stand up or cough. Millions of people each year undergo hernia repair surgery representing a billion dollar per year market for hernia repair medical devices like Ethicon's Physiomesh hernia repair screen.

Johnson & Johnson and Ethicon, a member of the company's medical device group, sought to capitalize on the enormous market for hernia repair in 2010 by rushing Physiomesh Composite Hernia Repair Device to market without adequately testing the device first. A critical part of Physiomesh contains a plastic called Polypropylene, a substance originally designed as a food packaging in single-use plastic bags. When placed inside the body, Polypropylene rapidly degrades causing a long list of severe adverse complications, all of which require revision surgery to remove the device and again repair the hernia. Since its inception, Johnson & Johnson has sold more than 300,000 Physiomesh Hernia Repair Devices that doctors have used to reinforce hernias repaired during minimally-invasive laparoscopic surgery. Up to 20% of Physiomesh implant patients required revision surgery. Due to abnormally high numbers of revision surgeries reported by a European health database, Ethicon issued a voluntary market withdrawal of the product with the advisory that the product would not be reintroduced to the market. Years earlier, Johnson & Johnson was forced to pay millions to settle claims by women that had developed permanent incontinence from Ethicon's transvaginal mesh device, a medical device very similar to Physiomesh.

Johnson & Johnson's efforts to cut their losses by voluntarily pulling Physiomesh may not be enough as thousands of Physiomesh patients are suing Ethicon and Johnson & Johnson for rushing a faulty medical device to market. Degradation of the Polypropylene in Physiomesh causes the device to shrink, crumple and sometimes break into pieces. A weakened Physiomesh can allow an original hernia to rupture again and require a second surgical repair.

The first Ethicon Physiomesh trials have been approved by a federal judge and consolidated into multidistrict litigation, scheduled to begin in September of 2019. If you have had laparoscopic hernia repair surgery using the Ethicon Physiomesh and experience pain and discomfort resulting in a second, revision surgery, you may consider speaking with a knowledgeable Physiomesh hernia attorney and see if you qualify to join the thousands of others who have filed a claim against Ethicon for rushing a faulty medical device to market.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.